Chinese Journal of Oncology : Impact Factor & More
pISSN: 0253-3766
Share this on:
Key Metrics
CiteScore 
1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chinese Journal of Oncology
Chinese Journal of Oncology Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Chinese Medical Journals Publishing House Co.Ltd |
Planning to publish in Chinese Journal of Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Journal of Oncology
CfDNA sequencing reveals response heterogeneity to first-line camrelizumab plus chemotherapy in esophageal squamous cell carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Efficacy and safety of combination immunotherapy for locally advanced esophageal carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Expert consensus on key clinical issues related to percutaneous cryoablation for lung tumors (2026 edition)
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
ShRNA-mediated downregulation of TERT inhibits melanoma in vitro and in vivo
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Advances in neoadjuvant therapy for EGFR-mutant non-small cell lung cancer
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
CfDNA sequencing reveals response heterogeneity to first-line camrelizumab plus chemotherapy in esophageal squamous cell carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Efficacy and safety of combination immunotherapy for locally advanced esophageal carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Expert consensus on key clinical issues related to percutaneous cryoablation for lung tumors (2026 edition)
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
ShRNA-mediated downregulation of TERT inhibits melanoma in vitro and in vivo
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Advances in neoadjuvant therapy for EGFR-mutant non-small cell lung cancer
- 23 Jun 2026
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
FAQs on Chinese Journal of Oncology
How many articles did Chinese Journal of Oncology publish last year? 
What is Citescore for Chinese Journal of Oncology?
Who is the publisher of Chinese Journal of Oncology?
